Tianjin TEDA Biomedical Engineering Company Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 369.355 million compared to CNY 358.751 million a year ago. Net loss was CNY 47.998 million compared to CNY 84.621 million a year ago. Basic loss per share from continuing operations was CNY 0.0253 compared to CNY 0.0447 a year ago.